Liquid Biopsy Market 2027 Top Players- Biocept, inc., Bio-Rad Laboratories, Inc., Lunglifeai, inc, Exosome Diagnostics

According to the latest study on ‘Liquid Biopsy Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product & Services, Sample, Circulating Biomarker, Application, and End User.’ The global liquid biopsy market was valued at US$ 3,861.49 million in 2019 and is projected to reach US$ 8,123.85 million by 2027; it is expected to grow with a CAGR of 9.9% during 2020–2027.The report provides trends prevailing in the global liquid biopsy market and the factors driving market along with those that act as hindrances.
Request Sample Copy Of this Report @ https://bit.ly/3gx3gzT
Based on product & services, the liquid biopsy market is segmented into equipment, reagents & kits and services. The reagents & kits segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR of 10.3% in the market during the forecast period. The growth of reagents & kit segment is attributed to the enhancement of solution to improve staining results and unique antibodies with fluorescent staining markers. There are various reagent & kits available in market for the detection of cancerous cell. For instance, MagMAX cell-free total nucleic acid isolation kit used to isolate and purify cfRNA and cfDNA from serum, plasma, or urine samples with the help of magnetic bead-based technology.

The increasing prevalence of cancer is the major factor driving the growth of the market. However, low sensitivity of liquid biopsy is likely to restrain the growth of the market during the forecast years.
The report segments global liquid biopsy market as follows:

Liquid Biopsy Market - By Product & Service
• Equipment
• Reagents & Kits
• Services
Liquid Biopsy Market - By Sample
• Blood Based
• Urine Based
• Other samples
Liquid Biopsy Market - By Circulating Biomarker
• Circulating Tumor Cells (CTC)
• Exosomes
• Free Nucleic Acid
Liquid Biopsy Market - By Application
• Noninvasive Prenatal Testing (NIPT)
• Oncology
• Transplant Diagnostics
• Other Applications

Applications Insights
Based on application, the liquid biopsy market has been segmented into noninvasive prenatal testing (NIPT), oncology, transplant diagnostics, and other applications. The oncology segment held the largest share of the market in 2019; however, noninvasive prenatal testing (NIPT) segment is estimated to register the highest CAGR in the market during the forecast period.
Purchase Copy of this Report @ https://bit.ly/2LgoDtw
End-UserInsights
Based on end user, the liquid biopsy market has been segmented into academic & research institutes, hospitals, reference laboratories, and other end users. The hospitals segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

Contact:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.